Page 1034 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1034

References     3


                      65. Carhuapoma JR, Gupta K, Coplin WM, Muddassir SM,       74. Badjatia  N.  Hyperthermia  and  fever  control  in  brain  injury.
                        Meratee MM. Treatment of refractory fever in the neurosci-  Crit Care Med. July 2009;37(7 suppl):S250-S257.
                        ences critical care unit using a novel, water-circulating cooling     75. Hoedemaekers CW, Ezzahti M, Gerritsen A, van der Hoeven JG.
                        device. A single-center pilot experience. J Neurosurg Anesthesiol.   Comparison of cooling methods to induce and maintain
                        October 2003;15(4):313-318.                             normo- and hypothermia in intensive care unit patients: a
                      66. Jiang J-Y, Gao G-Y, Li W-P, Yu M-K, Zhu C. Early indicators   prospective intervention study.  Crit Care (London, England).
                        of prognosis in 846 cases of severe traumatic brain injury.     2007;11(4):R91.
                        J Neurotrauma. 2002;19(7):869-874.                   76. Bernard GR, Wheeler AP, Russell JA, et al. The effects of
                      67. Castillo J, Davalos A, Marrugat J, Noya M. Timing for   ibuprofen on the physiology and survival of patients with
                        fever-related brain damage in acute ischemic stroke.  Stroke.   sepsis. The Ibuprofen in Sepsis Study Group. New Engl J Med.
                        1998;29(12):2455-2460.                                  1997;336(13):912-918.
                      68. Kazmers A, Groehn H, Meeker C. Do patients with acute deep     77. Gozzoli V, Schottker P, Suter PM, Ricou B. Is it worth treating
                        vein thrombosis have fever? Am Surg. 2000;66(6):598-601.  fever in intensive care unit patients? Preliminary results from a
                      69. Mason PJ, Morris VA, Balcezak TJ. Serotonin syndrome.   randomized trial of the effect of external cooling. Arch Intern
                        Presentation of 2 cases and review of the literature. Medicine.   Med. January 8, 2001;161(1):121-123.
                        2000;79(4):201-209.                                  78. Schulman CI, Namias N, Doherty J, et al. The effect of antipyretic
                      70. Buckley PF, Hutchinson M. Neuroleptic malignant syndrome.    therapy upon outcomes in critically ill patients: a randomized,
                        J Neurol, Neurosurg Psychiatry. 1995;58(3):271-273.     prospective  study.  [Erratum  appears  in  Surg  Infect  (Larchmt).
                                                                                2010 Oct;11(5):495 Note: Li, Pam [corrected to Li, Pamela];
                      71. Reulbach U, Dutsch C, Biermann T, et al. Managing an effec-  Alhaddad, Ahmed [corrected to Elhaddad, Ahmed]]. Surg Infect.
                        tive treatment for neuroleptic malignant syndrome. Crit Care   2005;6(4):369-375.
                        (London, England). 2007;11(1):R4.
                                                                             79. Schortgen F, Clabault K, Katsahian S, et al. Fever control using
                      72. Denborough  M.  Malignant  hyperthermia.  Lancet.  1998;   external cooling in septic shock: a randomized controlled trial.
                        352(9134):1131-1136.
                                                                                Am J Respir Crit Care Med. 2012;185(10):1088-1095.
                      73. Plaisance KI. Toxicities of drugs used in the management of
                        fever. Clin Infect Dis. 2000;31(suppl 5):S219-S223.


























































            Section05-O-ref.indd   3                                                                                   1/20/2015   4:51:16 PM
   1029   1030   1031   1032   1033   1034   1035   1036   1037   1038   1039